Business Context and Reporting Period
Company: MacroGenics, Inc. (MGNX)
Filing Type: Form 8-K (Current Report)
Report Date: March 9, 2026
Reporting Period: Year ended December 31, 2025
This filing announces the financial and operating results for the full year 2025. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text serves as a cover report and does not contain specific numerical data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1).
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the text of this Form 8-K. The document solely references the announcement of the 2025 results.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of 2025 results but does not include specific management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are described in this excerpt.
Legal Disclaimer: The information in this Form 8-K and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 9, 2026) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the 2025 operating results and any year-over-year comparisons.
- Check for any forward-looking statements or updated guidance included in the attached press release.
- Confirm the status of the company's cash position and liquidity as detailed in the full report.